‘Five days after’ contraceptive pill approved
August 14th, 2010 - 12:21 pm ICT by ANIMelbourne, Aug 14 (ANI): US regulatory agency FDA (Food and Drug Administration) has approved an emergency contraceptive pill that can prevent pregnancy if taken up to five days after unprotected sex.
FDA approved the pill, called Ella, following two phase III clinical trials tha confirmed its efficacy and safety.
Manufactured by French firm HRA Pharma, the pill “prevents pregnancy when taken orally within 120 hours (five days) after a contraceptive failure or unprotected intercourse,” News.com.au quoted the FDA statement.
However, the agency warned that it is not for routine use as a contraceptive.
The pill works by delaying ovulation and has side effects similar to other contraceptives.
The drug has been available in Europe since May 2009, under the name ellaOne, and will be distributed into the United States by New Jersey-based Watson Pharma. (ANI)
- FDA finds the new morning after pill safe - Jun 20, 2010
- FDA Says 'New Morning After Pill' is Effective and Safe - Jun 15, 2010
- Advisory panel to FDA approves five-day emergency contraceptive - Jun 18, 2010
- Green Signal To New Morning After Pill By FDA Advisory Panel - Jun 20, 2010
- FDA Consultants Endorse New 'Morning After' Pill - Jun 20, 2010
- New Morning after pill might be available to Americans soon - Jun 15, 2010
- US approves five-day emergency contraceptive - Aug 14, 2010
- EllaOne: Emergency contraception pill or abortive agent? - Feb 02, 2010
- The New Morning After Pill Proves To Be More Effective - Jun 15, 2010
- New pill two times more effective in stopping unwanted pregnancies - Jan 29, 2010
- Morning-after pill works up to 5 days after unprotected sex - Jan 31, 2010
- New Morning-After Pill Awaits FDA Approval - Jun 15, 2010
- New five-day emergency contraceptive on sale in Britain - Nov 01, 2010
- 1 in 5 Brit women blame drink or drugs for unprotected sex - Jan 01, 2011
- FDA approves first oral contraceptive that increases folate levels - Sep 27, 2010
Tags: clinical trials, contraceptive failure, contraceptives, efficacy, emergency contraceptive pill, fda, fda food, fda statement, food and drug, food and drug administration, hra pharma, melbourne, news com au, ovulation, phase iii, pregnancy, regulatory agency, unprotected intercourse, unprotected sex, watson pharma